Literature DB >> 9445116

Enhanced expression of TGF-betas and their receptors in human acute pancreatitis.

H Friess1, Z Lu, E Riesle, W Uhl, A M Bründler, L Horvath, L I Gold, M Korc, M W Büchler.   

Abstract

OBJECTIVES: To determine which mechanisms are involved in pancreatic remodeling, repair, and fibrosis after acute necrotizing pancreatitis (NP) in humans. SUMMARY BACKGROUND DATA: Transforming growth factor betas (TGF-betas) are multifunctional polypeptides that have been implicated in the regulation and formation of extracellular matrix and fibrosis. They exert their functions by binding to specific receptors. In this study, we analyze the expression of TGF-beta1, TGF-beta2, and TGF-beta3 and their receptors type I (Tbeta-RI [ALK5]), type II (Tbeta-RII), and type III (Tbeta-RIII) in NP. PATIENTS: Pancreatic tissue samples were obtained from 6 female and 8 male patients with a median age of 65 years (range, 37 to 77 years) undergoing surgery for NP. The median Ranson score of the patients was 6 (range, 2 to 9). The operation was performed a median 5.5 days (range, 4 to 17 days) after the onset of acute pancreatitis. Pancreatic tissue obtained from 12 previously healthy organ donors (6 male, 6 female; median age of 43 years) served as controls.
METHODS: The expression of TGF-beta1, TGF-beta2, TGF-beta3, Tbeta-RI (ALK5), Tbeta-RII, Tbeta-RIII, and collagen type I mRNA was analyzed by Northern blot analysis. In addition, immunohistochemical analysis using polyclonal antibodies was performed to detect TGF-beta1, TGF-beta2, TGF-beta3, Tbeta-RI (ALK5), and Tbeta-RII.
RESULTS: Northern blot analysis showed an increase in TGF-betas and their receptors in NP tissue samples compared with samples from normal controls. The increase was 3.5-fold for TGF-beta1 (p < 0.05), 2.7-fold for TGF-beta2 (p < 0.05), 3.5-fold for TGF-beta3 (p < 0.05), 10-fold for Tbeta-RI (ALK5) (p < 0.05), 5.7-fold for Tbeta-RII (p < 0.05), and 1.4-fold for Tbeta-RIII (not significant). Collagen type I mRNA was also markedly increased in NP samples and correlated with the level of TGF-betas. Immunohistochemical analysis demonstrated intense TGF-beta1, TGF-beta2, TGF-beta3, Tbeta-RI (ALK5), and Tbeta-RII immunoreactivity in the remaining acinar and ductal cells in most NP samples; in the normal control pancreas, there was weak to moderate immunoreactivity for these factors only in some acinar cells and a few ductal cells.
CONCLUSION: The marked increase in expression of TGF-betas and their signaling receptors Tbeta-RI (ALK5) and Tbeta-RII suggests a role for TGF-betas in the repair process after the onset of NP in humans and raises the possibility that TGF-betas might be involved in tissue remodeling and the fibrotic reaction that occurs in the pancreas after necrosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445116      PMCID: PMC1191178          DOI: 10.1097/00000658-199801000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  41 in total

1.  Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation.

Authors:  L Braun; J E Mead; M Panzica; R Mikumo; G I Bell; N Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

2.  Pathological anatomy and pathogenesis of acute pancreatitis.

Authors:  V Becker
Journal:  World J Surg       Date:  1981-05       Impact factor: 3.352

3.  Increased expression of transforming growth factor beta s after acute oedematous pancreatitis in rats suggests a role in pancreatic repair.

Authors:  E Riesle; H Friess; L Zhao; M Wagner; W Uhl; K Baczako; L I Gold; M Korc; M W Büchler
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

4.  Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta.

Authors:  C M Overall; J L Wrana; J Sodek
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

5.  Acute pancreatitis: a lethal disease of increasing incidence.

Authors:  A P Corfield; M J Cooper; R C Williamson
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

6.  Experimental pancreatitis in the rat. Changes in pulmonary phospholipids during sodium taurocholate-induced acute pancreatitis.

Authors:  H J Aho; R A Ahola; A M Tolvanen; T J Nevalainen
Journal:  Res Exp Med (Berl)       Date:  1983

7.  Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells.

Authors:  R Derynck; J A Jarrett; E Y Chen; D H Eaton; J R Bell; R K Assoian; A B Roberts; M B Sporn; D V Goeddel
Journal:  Nature       Date:  1985 Aug 22-28       Impact factor: 49.962

8.  Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis.

Authors:  H J Aho; S M Koskensalo; T J Nevalainen
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

9.  Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue.

Authors:  M Lampel; H F Kern
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-03-11

10.  Time course and cellular source of pancreatic regeneration following acute pancreatitis in the rat.

Authors:  H P Elsässer; G Adler; H F Kern
Journal:  Pancreas       Date:  1986       Impact factor: 3.327

View more
  25 in total

1.  Involvement of apoptosis of alveolar epithelial cells in acute pancreatitis-associated lung injury.

Authors:  Yao-Zong Yuan; Zi-Hua Gong; Kai-Xian Lou; Shui-Ping Tu; Zu-Kang Zhai; Jia-Yu Xu
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  SMAD3/Stat3 Signaling Mediates β-Cell Epithelial-Mesenchymal Transition in Chronic Pancreatitis-Related Diabetes.

Authors:  Xiangwei Xiao; Shane Fischbach; Tina Zhang; Congde Chen; Qingfeng Sheng; Ray Zimmerman; Sneha Patnaik; Joseph Fusco; Yungching Ming; Ping Guo; Chiyo Shiota; Krishna Prasadan; Nupur Gangopadhyay; Sohail Z Husain; Henry Dong; George K Gittes
Journal:  Diabetes       Date:  2017-08-03       Impact factor: 9.461

3.  Role of Radiation-induced TGF-beta Signaling in Cancer Therapy.

Authors:  Horatiu C Dancea; Mohammed M Shareef; Mansoor M Ahmed
Journal:  Mol Cell Pharmacol       Date:  2009

4.  Connective tissue growth factor is involved in pancreatic repair and tissue remodeling in human and rat acute necrotizing pancreatitis.

Authors:  Fabio F di Mola; Helmut Friess; Erick Riesle; Alexander Koliopanos; Peter Büchler; Zhaowen Zhu; David R Brigstock; Murray Korc; Markus W Büchler
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

5.  Bak expression and cell death occur in peritumorous tissue but not in pancreatic cancer cells.

Authors:  H U Graber; H Friess; A Zimmermann; M Korc; G Adler; R Schmid; M W Büchler
Journal:  J Gastrointest Surg       Date:  1999 Jan-Feb       Impact factor: 3.452

Review 6.  TGFbeta-induced fibrogenesis of the pancreas.

Authors:  Andre Menke; Guido Adler
Journal:  Int J Gastrointest Cancer       Date:  2002

Review 7.  Mechanisms of cancer dissemination along nerves.

Authors:  Moran Amit; Shorook Na'ara; Ziv Gil
Journal:  Nat Rev Cancer       Date:  2016-05-06       Impact factor: 60.716

8.  Parathyroid Hormone-Related Protein Interacts With the Transforming Growth Factor-β/Bone Morphogenetic Protein-2/Gremlin Signaling Pathway to Regulate Proinflammatory and Profibrotic Mediators in Pancreatic Acinar and Stellate Cells.

Authors:  Vandanajay Bhatia; Yanna Cao; Tien C Ko; Miriam Falzon
Journal:  Pancreas       Date:  2016 May-Jun       Impact factor: 3.327

9.  Expression of transforming growth factor betas and their signaling receptors in stone-containing intrahepatic bile ducts and cholangiocarcinoma.

Authors:  King-Teh Lee; Tsan-Shium Liu
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

Review 10.  Regulation of pancreatic function by connective tissue growth factor (CTGF, CCN2).

Authors:  Alyssa Charrier; David R Brigstock
Journal:  Cytokine Growth Factor Rev       Date:  2012-08-10       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.